FDA.reportPublic FDA data

simeprevir Oral Capsule

RxCUI
1482800
RxNorm name
simeprevir Oral Capsule
Term type
SCDF
Status
Active
Updated
2026-08-10 19:19:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012014
Active start
012014
Multiple ingredient
NO
Branded
NO

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
simeprevir1482790

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRsimeprevir Oral Capsule1NAMES
RxNorm Namesimeprevir Oral Capsule1NAMES
TTYSCDF1ATTRIBUTES
RxCUI14828001CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCJ05APAntivirals for treatment of HCV infectionsATC1-4simeprevir
MEDRTD000069616SimeprevirCHEMhas_ingredientsimeprevir
MEDRTD019698Hepatitis C, ChronicDISEASEmay_treatsimeprevir
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAhas_moasimeprevir
MEDRTN0000182638HCV NS3/4A Protease InhibitorsMOAhas_moasimeprevir
MEDRTN0000190107Organic Anion Transporting Polypeptide 1B1 InhibitorsMOAhas_moasimeprevir
MEDRTN0000190108Organic Anion Transporting Polypeptide 1B3 InhibitorsMOAhas_moasimeprevir
MEDRTN0000185503P-Glycoprotein InhibitorsMOAhas_moasimeprevir

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
CODESUSPm9066
SOURCESSourceUnited States Pharmacopeia